The Penicillins and Streptomycins in Bulk Market in China exhibited a consistent increase from 2013 to 2021, initially growing from $0.03 to $0.066 per capita. However, from 2021 to 2023, there was relative stabilization, with values oscillating between $0.062 and $0.063. The year-on-year variation from 2022 to 2023 was a slight increase of 1.6%. The compound annual growth rate (CAGR) over the last five years was approximately 2.16%, indicating moderate market expansion.

Future trends to watch:

Continued demand driven by increasing antibiotic use in China’s healthcare system.
Impact of governmental regulations and antibiotic resistance measures.
Potential market shifts due to technological advancements and alternative antibiotics.